$3.660
-0.286 (-7.81%)Zum Schluss
Umsatzquellen von XAIR
Beyond Air Inc (XAIR) generates its revenue primarily from Beyond Air, which accounts for 100.0% of total sales, equivalent to $1.77M. Understanding this concentration is critical for investors evaluating how XAIR navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitabilität und Margen von XAIR
Evaluating the bottom line, Beyond Air Inc maintains a gross margin of 12.73%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -373.98%, while the net margin is -461.20%. These profitability ratios, combined with a Return on Equity (ROE) of -561.77%, provide a clear picture of how effectively XAIR converts its operational activities into shareholder value.
XAIR im Vergleich zur Peergroup
In the context of the broader market, XAIR competes directly with industry leaders such as VVOS and BJDX. With a market capitalization of $3.91M, it holds a significant position in the sector. When comparing efficiency, XAIR's gross margin of 12.73% stands against VVOS's 47.41% and BJDX's N/A. Such benchmarking helps identify whether Beyond Air Inc is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Beyond Air Inc
Beyond Air has shown inconsistent revenue growth, with total revenue reaching $2,194,000 in Q3 2026, but it continues to report net losses, with a net income of -$7,336,000 for the same quarter. The gross margin has fluctuated, with the latest figure at 4.93%, indicating limited profitability.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.